Effects of intravenous infusion lidocaine on paravertebral nerve block for the treatment of patients with subacute herpetic neuralgia

刘云琴,高鸿,贺纯静,康新国
DOI: https://doi.org/10.3760/cma.j.cn101658-20220511-00074
2023-01-01
Abstract:Objective:To explore the effects of lidocaine intravenous infusion on paravertebral nerve block for the treatment of patients with subacute herpetic neuralgia (SHN).Methods:From November 2020 to November 2021, 80 patients with thoracolumbar SHN hospitalized, aged 45-75 years old, gender not limited, persistent pain for 1 to 3 months, visual analogue scale (VAS) ≥4, in the Department of Painology, Guizhou Provincial People's Hospital were collected. According to the random data table, all patients were divided into paravertebral nerve block group (group N) and lidocaine combined with paravertebral nerve block group (group L), 40 cases in each group. All patients were routinely treated with medication (methobalamin tablet + pregabalin capsule) in both groups. The patients received paravertebral nerve block, once a day, under the guidance of ultrasound in both groups. The nerve block solution (2% lidocaine hydrochloride injection 2 ml + dexamethasone sodium phosphate injection 2.5 mg + vitamin B 12 injection 0.5 mg + 0.9% sodium chloride injection add up to 5 ml) was injected into the paravertebral space under the guidance of ultrasound. In group L, intravenous infusion of lidocaine (3 mg/kg) was added, with infusion rate 25 ml/h, daily for 5 consecutive days. VAS was recorded before the treatment (T0) and at 1, 3, 5, 30, 60 and 90 d (T1-T6) after the treatment. VAS, self-rating scale of sleep (SRSS), local skin temperature, dose of analgesic drugs, and the occurrence of adverse reactions were recorded. Results:VAS, SRSS and the dosage of analgesics were decreased at T3-T6 compared with pre-treatment (all P<0.05). Compared with the group N, VAS, SRSS and the dosage of analgesics at T3-T6 were significantly decreased in group L (all P<0.05). Compared with T0, the skin temperature was decreased at T3 in two groups (all P<0.05). Compared with the group N, the skin temperature was decreased in group L at T3 (all P<0.05). The incidence of PHN was significantly lower in the group L than that in the group N ( P<0.05). No serious complications occurred in both groups. Conclusion:Intravenous infusion of lidocaine can optimize the efficacy of paravertebral nerve block in the treatment of SHN, reduce the dosage of analgesic drugs and the incidence of postherpetic neuralgia.
What problem does this paper attempt to address?